- Home
- LSF vs GNTA Comparison
LSF vs GNTA Comparison
Compare LSF & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.37
HOLD
Current Price
$1.87
Company Overview
Basic Information| Metric | LSF | GNTA |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 39.4M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LSF | GNTA |
|---|---|---|
| Price | $2.37 | $1.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 118.0K | 111.6K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $48,146,862.00 | N/A |
| Revenue This Year | $18.05 | N/A |
| Revenue Next Year | $17.53 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.73 | N/A |
| 52 Week Low | $2.18 | $1.35 |
| 52 Week High | $10.90 | $10.00 |
Technical Indicators
Market Signals| Indicator | LSF | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 29.01 | 40.49 |
| Support Level | $2.47 | $1.80 |
| Resistance Level | $2.78 | $2.20 |
| Average True Range (ATR) | 0.20 | 0.24 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 28.79 | 59.77 |
Price Performance
Historical Comparison LSF
GNTA
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.